A Clinical Study of MK-8294 in Participants With Advanced Solid Tumors (MK-8294-001)
A Clinical Study of MK-8294 in Participants With Advanced Solid Tumors (MK-8294-001)
Recruiting · NCT07030712 · Registry updated 2026-09-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Clinical Study of MK-8294 in Participants With Advanced Solid Tumors (MK-8294-001) | Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, metastatic neoplasm, neoplasm | Recruiting | Phase 1 | 2026-09-11 | NCT07030712 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Merck Sharp & Dohme LLC | 650 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Houston Methodist Hospital ( Site 0103) | Houston | United States | 1 |
| John Theurer Cancer Center at Hackensack University Medical Center ( Site 0105) | Hackensack | United States | 1 |
| Nederlands Kanker Instituut - Antoni van Leeuwenhoek - NKI-AVL ( Site 0300) | Amsterdam | Netherlands | 1 |
| Northwestern University ( Site 0101) | Chicago | United States | 1 |
| Radboudumc ( Site 0301) | Nijmegen | Netherlands | 1 |
| Rambam Health Care Campus ( Site 0201) | Haifa | Israel | 1 |
| Sheba Medical Center ( Site 0200) | Ramat Gan | Israel | 2 |